Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Sarcoidosis, anterior pituitary failure, and diabetes insipidus

  • 20 Accesses

  • 5 Citations

Summary

We report a case of sarcoidosis and anterior pituitary failure in which frank diabetes insipidus was unmasked by glucocorticoid replacement therapy.

This is a preview of subscription content, log in to check access.

References

  1. Aubrey, R. H., Nankin, H. R., Moses, A. M. and Streeten, D. H. P. 1965. Measurement of the osmotic threshold for vasopressin release in human subjects, and its modification by cortisol. J. Clin. Endocrinol. 21, 337–365.

  2. Davis, J. C. and Hipkin, J. L. 1977. Cinical Endocrine Pathology. Blackwell, Oxford, p. 77.

  3. Leaf, A., Mamby, A. R., Rasmussen, H. and Marasco, J. P. 1952. Some hormonal aspects of water excretion in man. J. Clin. Invest. 31, 914–827.

  4. Skrabanek, P., Balfe, A., Webb, M., Maguire, J. and Powell, D. 1981. Electroconvulsive therapy (ECT) increases plasma growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone but not thyrotropin or substance P. Psychoneuroendocrinology 6, 261–267.

  5. Von Hann, F. 1918. Ueber die Bedengtung der Hypophysenveränderungen bei Diabetes insipidus. Frankfurt Z. Path. 21, 337–365.

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Garrett, P., Langan, C., Egan, J. et al. Sarcoidosis, anterior pituitary failure, and diabetes insipidus. Ir J Med Sci 152, 136–138 (1983). https://doi.org/10.1007/BF02960054

Download citation

Keywords

  • Luteinizing Hormone
  • Sarcoidosis
  • Diabetes Insipidus
  • Thyrotrophin Release Hormone
  • Luteinizing Hormone Release Hormone